Kala Pharmaceuticals, Inc.
Crystalline forms of therapeutic compounds and uses thereof
Last updated:
Abstract:
Described herein are crystalline forms of Compound 1 useful for the prevention and treatment of angiogenic ocular conditions; methods of treating a disease comprising; processes for preparing; and kits comprising, the same. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
13 Mar 2020
Issue date:
31 Aug 2021